AIGH Capital Management »

In8bio shares owned by AIGH Capital Management

Quarter-by-quarter ownership of In8bio (INAB) shares owned by AIGH Capital Management from 13F filings

Historical chart of AIGH Capital Management investment in In8bio

Tip: Access up to 7 years of quarterly data

All positions including In8bio held by AIGH Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in In8bio by AIGH Capital Management

Quarter filed Position value Share count Share price at filing
2024-03-31 $3.4M 2.9M 1.18
2023-12-31 $5.2M 4.1M 1.27

More positions owned by AIGH Capital Management

Spdr Ser Tr S&p Biotech Put Option (XBI)
Micron Technology Call Option (MU)
Scpharmaceuticals (SCPH)
Electrovaya Com New (ELVA)
Ouster Com New (OUST)
Cellectar Biosciences Com New (CLRB)
Delcath Sys Com New (DCTH)
Myomo Com New (MYO)
Tela Bio (TELA)
Humacyte (HUMA)
Beyond Air (XAIR)
Coya Therapeutics Common Stock (COYA)
Fennec Pharmaceuticals (FENC)
Ideal Pwr Com New (IPWR)
Eagle Pharmaceuticals (EGRX)

View all positions for AIGH Capital Management

Top funds holding In8bio

AIGH Capital Management
Vanguard Group
Ensign Peak Advisors
683 Capital Management
Sigma Planning
Alyeska Investment Group
Voss Capital
Geode Capital Management
Stonegate Investment Group
Rock Creek Group
Bridgeway Capital Management
Texas Capital Bank Wealth Management Services
Northern Trust
Laird Norton Tyee Trust
Two Sigma Investments

View all funds holding In8bio